Filion; Mario C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Filion; Mario C..The latest application filed is for "bacterial ribonucleic acid cell wall compositions and methods of making and using them".

Company Profile

0.17.22

Filion; Mario C. - Laval CA
Filion, Mario C. - Quebec CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them App 20160151475 - Phillips; Nigel C. ; et al.	2016-06-02
Bacterial ribonucleic acid cell wall compositions and methods of making and using them Grant 9,220,765 - Phillips , et al. December 29, 2	2015-12-29
Bacterial ribonucleic acid cell wall compositions and methods of making and using them Grant 9,180,176 - Phillips , et al. November 10, 2	2015-11-10
Bacterial Ribonucleic Acid Cell Wall Compositions And Methods Of Making And Using Them App 20150224183 - Phillips; Nigel C. ; et al.	2015-08-13
Bacterial ribonucleic acid cell wall compositions and methods of making and using them Grant 9,044,422 - Phillips , et al. June 2, 2	2015-06-02
Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them App 20140322372 - Phillips; Nigel C. ; et al.	2014-10-30
Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them App 20140170189 - Phillips; Nigel C. ; et al.	2014-06-19
Bacterial Ribonucleic Acid Cell Wall Compositions And Methods Of Making And Using Them App 20130142828 - Phillips; Nigel C. ; et al.	2013-06-06
Oligonucleotide compositions and their use to induce apoptosis Grant 8,350,016 - Phillips , et al. January 8, 2	2013-01-08
Oligonucleotide Compositions and Their Use to Induce Apoptosis App 20110160291 - Phillips; Nigel C. ; et al.	2011-06-30
Non-dna Base-containing Polynucleotide Compositions And Their Use For The Modulation Of Immune Responses App 20110111016 - Phillips; Nigel C. ; et al.	2011-05-12
Oligonucleotide compositions and their use to induce apoptosis Grant 7,893,242 - Phillips , et al. February 22, 2	2011-02-22
Modulation of Fas and FasL expression Grant 7,662,792 - Phillips , et al. February 16, 2	2010-02-16
Therapeutically useful triethyleneglycol cholesteryl oligonucleotides Grant 7,635,686 - Phillips , et al. December 22, 2	2009-12-22
Oligonucleotide compositions and their use for the modulation of immune responses Grant 7,371,734 - Phillips , et al. May 13, 2	2008-05-13
Oligonucleotide Compositions and Their Use to Induce Apoptosis App 20080081793 - Phillips; Nigel C. ; et al.	2008-04-03
Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides App 20080077372 - Phillips; Nigel C. ; et al.	2008-03-27
Oligonucleotide compositions and their use to induce apoptosis Grant 7,199,228 - Phillips , et al. April 3, 2	2007-04-03
Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides Grant 7,200,531 - Phillips , et al. April 3, 2	2007-04-03
Oligonucleotide compositions and their use to induce differentiation of cells App 20070010472 - Filion; Mario C. ; et al.	2007-01-11
Therapeutically useful synthetic oligonucleotides Grant 7,157,436 - Phillips , et al. January 2, 2	2007-01-02
Hyaluronic acid in the treatment of cancer Grant 7,125,858 - Filion , et al. October 24, 2	2006-10-24
Oligonucleotide compositions and their use to induce differentiation of cells Grant 7,087,586 - Filion , et al. August 8, 2	2006-08-08
Method for the treatment of inflammation Grant 6,890,911 - Phillips , et al. May 10, 2	2005-05-10
Chemotherapeutic composition and method App 20040242524 - Phillips, Nigel C. ; et al.	2004-12-02
Chemotherapeutic composition and method Grant 6,809,081 - Phillips , et al. October 26, 2	2004-10-26
Composition and method for inducing apoptosis in prostate cancer cells Grant 6,794,368 - Phillips , et al. September 21, 2	2004-09-21
Oligonucleotide compositions and their use for the modulation of immune responses App 20040058883 - Phillips, Nigel C. ; et al.	2004-03-25
Hyaluronic acid in the treatment of cancer App 20030176381 - Filion, Mario C. ; et al.	2003-09-18
Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides App 20030144233 - Phillips, Nigel C. ; et al.	2003-07-31
Therapeutically useful triethyleneglycol cholesteryl oligonucleotides App 20030125290 - Phillips, Nigel C. ; et al.	2003-07-03
Modulation of Fas and FasL expression App 20030119776 - Phillips, Nigel C. ; et al.	2003-06-26
Oligonucleotide compositions and their use to induce apoptosis App 20030113763 - Phillips, Nigel C. ; et al.	2003-06-19
Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls App 20030044352 - Phillips, Nigel C. ; et al.	2003-03-06
Oligonucleotide compositions and their use to induce differentiation of cells App 20030045493 - Filion, Mario C. ; et al.	2003-03-06
Modulation of Fas and FasL expression App 20020091095 - Phillips, Nigel C. ; et al.	2002-07-11
Therapeutically useful synthetic oligonucleotides App 20010041681 - Phillips, Nigel C. ; et al.	2001-11-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.